X0306 4 2022-10-31 0 0001833769 Hyperfine, Inc. HYPR 0001898560 Siddiqui Khan C/O HYPERFINE, INC. 351 NEW WHITFIELD STREET GUILFORD CT 06437 0 1 0 0 CMO and Chief Strategy Officer Stock Option (right to buy) 3.76 2022-10-31 4 D 0 235145 D 2030-01-27 Class A Common Stock 235145 0 D Stock Option (right to buy) 0.91 2022-10-31 4 A 0 235145 A 2030-01-27 Class A Common Stock 235145 235145 D Stock Option (right to buy) 3.27 2022-10-31 4 D 0 54037 D 2031-04-14 Class A Common Stock 54037 0 D Stock Option (right to buy) 0.91 2022-10-31 4 A 0 54037 A 2031-04-14 Class A Common Stock 54037 54037 D Stock Option (right to buy) 5.24 2022-10-31 4 D 0 1796 D 2031-05-12 Class A Common Stock 1796 0 D Stock Option (right to buy) 0.91 2022-10-31 4 A 0 1796 A 2031-05-12 Class A Common Stock 1796 1796 D Stock Option (right to buy) 3.90 2022-10-31 4 D 0 110000 D 2032-02-09 Class A Common Stock 110000 0 D Stock Option (right to buy) 0.91 2022-10-31 4 A 0 110000 A 2032-02-09 Class A Common Stock 110000 110000 D Stock Option (right to buy) 3.90 2022-10-31 4 D 0 74000 D 2032-02-09 Class A Common Stock 74000 0 D Stock Option (right to buy) 0.91 2022-10-31 4 A 0 74000 A 2032-02-09 Class A Common Stock 74000 74000 D The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 161,657 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date. The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of which 23,646 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date. The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on December 22, 2021, of whlich 636 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date. The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on February 9, 2022, of which 45,833 shares vested and the remainder of the options vesting in equal monthly installments, subject to Mr. Siddiqui's continued service on each vesting date. The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date. /s/ Neela Paykel, Attorney-in-Fact 2022-11-01